- Fund Type: SICAV
- Objective: Growth
- Asset Class: Equity
- Geographic Focus: Spain
Fusopar SICAV SA
+ Add to WatchlistS1085:SM
5.0700 EUR 0.0200 0.40%As of 10:00:38 ET on 06/18/2013.
Snapshot for Fusopar SICAV SA (S1085)
| Open: | 5.0700 | High - Low: | 5.0700 - 5.0700 | Primary Exchange: | Continuous |
|---|---|---|---|---|---|
| Volume: | 0 | 52-Week Range: | 4.4800 - 5.2500 | Beta vs IBEX: | 0.4945 |
Fund Profile & Information for S1085
Fusopar SICAV SA is an open-end investment company incorporated in Spain. The investment company's objective is capital growth. It primarily invests in equity securities.
| Inception Date: | 2006-10-17 | Telephone: | 34-91-561-1408 |
|---|---|---|---|
| Managers: | - | ||
| Web Site: | www.arcalia.es | ||
Fundamentals for S1085
| NAV | (on 2013-06-17) 5.0719 |
|---|---|
| Assets (M) | (on 2013-04-04) 13.4077 |
| Shares out (M) | 0.00 |
| Market Cap (M) | 0.00 |
| % Premium | -0.43 |
| Average 52-Week % Premium | -0.0510 |
| Fund Leveraged | N |
Dividends for S1085
No dividends reported
Performance for S1085
| 1-Month | -2.87% | 1-Year | +12.67% |
|---|---|---|---|
| 3-Month | -0.78% | 3-Year | -1.22% |
| Year To Date | +4.32% | 5-Year | -2.48% |
| Expense Ratio | - |
Top Fund Holdings for S1085
Filing Date: 04/30/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| SPGB 4.1 07/30/18 | 760 | 824,783 | 7.211% |
| SPGB 4 ¼ 10/31/16 | 704 | 758,994 | 6.636% |
| IBEX 35 INDX FUTR May13 | 8 | 673,328 | 5.887% |
| Telefonica SA | 40,702 | 453,420 | 3.964% |
| Total SA | 10,200 | 390,354 | 3.413% |
| Sanofi | 4,176 | 347,527 | 3.038% |
| March International - March Vi | 26,720 | 329,448 | 2.880% |
| Cie Generale des Etablissement | 5,000 | 320,650 | 2.803% |
| Pfizer Inc | 13,450 | 297,016 | 2.597% |
| Bayerische Motoren Werke AG | 3,686 | 259,089 | 2.265% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page